Bluemtec
Key metrics
Earnings
| Revenue, Q3 2026 | ₩90.4bn |
|---|---|
| Revenue QoQ | +64.4% |
| Revenue YoY | +73.4% |
| Operating income, Q3 2026 | ₩1.1bn |
| Operating income QoQ | +496.4% |
| Operating income YoY | +212.2% |
Share buybacks
| Buyback decided, last 3 months | ₩0 |
|---|---|
| Buyback decided, last 3 months, % of shares | 0.0% |
| Shares acquired, last 3 months | ₩0 |
| Shares acquired, last 3 months, % of shares | 0.0% |
| Treasury shares cancelled, last 3 months | ₩0 |
| Treasury shares cancelled (number), last 3 months | 0 shares |
| Treasury shares cancelled, last 3 months, % of shares | 0.0% |
| Buyback decided, last 12 months | ₩1.0bn |
| Buyback decided, last 12 months, % of shares | Not available |
| Shares acquired, last 12 months | ₩0 |
| Shares acquired, last 12 months, % of shares | 0.0% |
| Treasury shares cancelled, last 12 months | ₩0 |
| Treasury shares cancelled (number), last 12 months | 0 shares |
| Treasury shares cancelled, last 12 months, % of shares | 0.0% |
Potential dilution
| CB/BW/EB issued, last 12 months | ₩44.0bn |
|---|---|
| Rights offering new shares, last 12 months | 0 shares |
| Potential new shares, last 12 months | 14,885,916 shares |
| Potential new shares, % of shares | 44.0% |
| Conversion price adjustments, last 12 months | 0 |
Supply contracts
| Supply contracts, last 12 months | ₩0 |
|---|---|
| Supply contracts vs prior-year revenue | 0.0% |
| Contracts without a KRW amount | 0 contracts without a KRW amount excluded |
Disclosure activity
| DART filings, last 3 months | 10 |
|---|---|
| DART filings, previous 3 months | 12 |
Insider transactions
| Open-market buys, last 12 months (shares) | 76,816 shares |
|---|---|
| Open-market buys, last 12 months (amount) | ₩206m |
| Open-market sells, last 12 months (shares) | 0 shares |
| Open-market sells, last 12 months (amount) | ₩0 |
| Net open-market buying, last 12 months (shares) | 76,816 shares |
| Insiders who bought, last 12 months | 2 |
Insider transactions (last 12 months)
Open-market buys: 76,816 shares (₩206m). Open-market sells: 0 shares (₩0). Net open-market buying: +76,816 shares. Insiders who bought: 2.
| Trade date | Insider (role) | Type | Shares | Price | Amount | |
|---|---|---|---|---|---|---|
| May 25, 2026 | Yeon Je-ryang (Registered director, Controlling shareholder) | Open-market buy | +75,456 shares | ₩2,651 | ₩200m | |
| Nov 25, 2025 | Yang Mun-sul (Registered director) | Open-market buy | +1,360 shares | ₩4,410 | ₩6m |
Annual financials
| Year | Revenue | Operating income |
|---|---|---|
| 2025 | ₩185.9bn | -₩2.0bn |
| 2024 | ₩133.3bn | -₩6.9bn |
| 2023 | ₩113.9bn | ₩1.3bn |
Filing timeline
-
Bluemtec Major Shareholder Change: 7,131,777 Shares Sold to KDBI Healthcare
Bluemtec filed a major shareholder change in which Yeon Je-ryang and three others sold 7,131,777 shares to KDBI Healthcare Value-Up Co., Ltd. at ₩3,235 per share, a deal amount of ₩23.1bn under a contract dated Oct 8, 2026. KDBI Healthcare Value-Up Co., Ltd. is expected to become the new major shareholder with a 21.1% stake. By our calculation, the deal amount is 12.4% of FY2025 revenue.
-
Bluemtec Issues ₩36.0bn Convertible Bonds Maturing Nov 6, 2033
Bluemtec filed notice of convertible bonds with a face amount of ₩36.0bn, a conversion price of ₩3,235 and a 0.0% coupon, maturing Nov 6, 2033. On conversion they could issue 11,128,284 shares, equal to 32.9% of total shares, with a refixing floor price of ₩2,265. The face amount equals 19.4% of FY2025 revenue by our calculation.